Canada - English - Health Canada

glaxo wellcome inc. - ergotamine tartrate; cyclizine hydrochloride; caffeine - tablet - 2mg; 50mg; 100mg - ergotamine tartrate 2mg; cyclizine hydrochloride 50mg; caffeine 100mg - sympatholytic (adrenergic blocking) agents

Namibia - English - Namibia Medicines Regulatory Council

inova pharmaceuticals (pty) ltd - ergotamine tartrate; cyclizine hydrochloride; caffeine hydrate - tablet - each tablet contains ergotamine ; tartrate ep 2.0mg, cyclizine hydrochloride; bp 50,0mg and caffeine bp equivalent to ; caf

Canada - English - Health Canada

pharmascience inc - dihydroergotamine mesylate - liquid - 4mg - dihydroergotamine mesylate 4mg - sympatholytic (adrenergic blocking) agents

Canada - English - Health Canada

pharmascience inc - dihydroergotamine mesylate - liquid - 1mg - dihydroergotamine mesylate 1mg - sympatholytic (adrenergic blocking) agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (canada) - dihydroergotamine mesilate - solution for injection - 1mg/1ml

United States - English - NLM (National Library of Medicine)

hikma farmaceutica - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) -

United States - English - NLM (National Library of Medicine)

it3 medical llc - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate injection, usp is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp 3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings: cyp 3a4 inhibitors) dihydroergotamine mesylate injection, usp should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm including prinzmetal's variant angina. (see

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bosnalijek d.d. - propyphenazone, caffeine, camylofin (camylofin hydrochloride), mecloxamine (mecloxamine citrate), ergotamine (ergotamine tartrate) - tablets film-coated - 200mg+ 80mg+ 25mg+ 20mg+ 0,75mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bosnalijek d.d. - propyphenazone, caffeine, camylofin (camylofin hydrochloride), mecloxamine (mecloxamine citrate), ergotamine (ergotamine tartrate) - tablets film-coated - 200mg+ 80mg+ 25mg+ 20mg+ 0,75mg

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - caffeine, cyclizine hydrochloride, ergotamine tartrate - tablet - caffeine 100 mg cyclizine hydrochloride 50 mg ergotamine tartrate 2 mg - analgesics